$17.00
-1.03-5.71%
Last update: Nov 6, 7:04 AM
Relay Therapeutics Inc (RLAY) Stock Price, Quote, News & History
RLAYNASDAQ
Relay Therapeutics reported early Phase 2 data showing lesion reduction and symptom improvement with zovegalisib.
You can purchase shares of Relay Therapeutics (NASDAQ:RLAY) through any online brokerage.
Other companies in Relay Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Relay Therapeutics has a consensus price target of $21.95.
The stock price for Relay Therapeutics (NASDAQ: RLAY) is $17.2 last updated November 6, 2026 at 7:04 AM EST.
There are no upcoming dividends for Relay Therapeutics.
Relay Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Relay Therapeutics.
Relay Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and...
